These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 38002033)

  • 1. An Overview of Chronic Kidney Disease Pathophysiology: The Impact of Gut Dysbiosis and Oral Disease.
    Altamura S; Pietropaoli D; Lombardi F; Del Pinto R; Ferri C
    Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.
    Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR
    Pflugers Arch; 2020 Mar; 472(3):303-320. PubMed ID: 32064574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
    Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
    Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Kidney Disease and Gut Microbiota: What Is Their Connection in Early Life?
    Hsu CN; Tain YL
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of gut microbiota: How it could play roles beyond the digestive system on development of cardiovascular and renal diseases.
    Suganya K; Son T; Kim KW; Koo BS
    Microb Pathog; 2021 Mar; 152():104583. PubMed ID: 33164814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary Components That May Influence the Disturbed Gut Microbiota in Chronic Kidney Disease.
    Mafra D; Borges N; Alvarenga L; Esgalhado M; Cardozo L; Lindholm B; Stenvinkel P
    Nutrients; 2019 Feb; 11(3):. PubMed ID: 30818761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
    Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease.
    Jazani NH; Savoj J; Lustgarten M; Lau WL; Vaziri ND
    Diseases; 2019 Feb; 7(1):. PubMed ID: 30781823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota issue in CKD: how promising are gut-targeted approaches?
    Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L
    J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease.
    Taguchi K; Fukami K; Elias BC; Brooks CR
    Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34069405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota-Targeted Interventions in the Management of Chronic Kidney Disease.
    Sumida K; Pierre JF; Yuzefpolskaya M; Colombo PC; Demmer RT; Kovesdy CP
    Semin Nephrol; 2023 Mar; 43(2):151408. PubMed ID: 37619529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
    Lau WL; Savoj J; Nakata MB; Vaziri ND
    Clin Sci (Lond); 2018 Mar; 132(5):509-522. PubMed ID: 29523750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis.
    Kuraji R; Shiba T; Dong TS; Numabe Y; Kapila YL
    World J Gastroenterol; 2023 Feb; 29(6):967-996. PubMed ID: 36844143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical impact of gut microbiota in chronic kidney disease.
    Kim SM; Song IH
    Korean J Intern Med; 2020 Nov; 35(6):1305-1316. PubMed ID: 32872729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic ties: Unraveling the complex relationship between endocrine disrupting chemicals and chronic kidney disease.
    Ramya Ranjan Nayak SP; Boopathi S; Haridevamuthu B; Arockiaraj J
    Environ Pollut; 2023 Dec; 338():122686. PubMed ID: 37802289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blueberry, cranberry, raspberry, and strawberry as modulators of the gut microbiota: target for treatment of gut dysbiosis in chronic kidney disease? From current evidence to future possibilities.
    Coutinho-Wolino KS; Melo MFS; Mota JC; Mafra D; Guimarães JT; Stockler-Pinto MB
    Nutr Rev; 2024 Jan; 82(2):248-261. PubMed ID: 37164634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gut microbiome tango in the progression of chronic kidney disease and potential therapeutic strategies.
    Tang Z; Yu S; Pan Y
    J Transl Med; 2023 Oct; 21(1):689. PubMed ID: 37789439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.